1ST Source Bank’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$28.3M Sell
30,771
-887
-3% -$899K 1.46% 12
2025
Q4
$34M Sell
31,658
-1,697
-5% -$1.62M 1.78% 11
2025
Q3
$25.4M Sell
33,355
-983
-3% -$732K 1.34% 11
2025
Q2
$26.8M Sell
34,338
-679
-2% -$528K 1.48% 11
2025
Q1
$28.9M Sell
35,017
-770
-2% -$641K 1.7% 11
2024
Q4
$27.6M Sell
35,787
-528
-1% -$437K 1.58% 11
2024
Q3
$32.2M Sell
36,315
-649
-2% -$583K 1.82% 11
2024
Q2
$33.5M Sell
36,964
-843
-2% -$674K 1.96% 10
2024
Q1
$29.4M Sell
37,807
-255
-0.7% -$181K 1.71% 10
2023
Q4
$22.2M Sell
38,062
-1,571
-4% -$917K 1.34% 12
2023
Q3
$21.3M Sell
39,633
-1,201
-3% -$619K 1.45% 12
2023
Q2
$19.2M Sell
40,834
-2,899
-7% -$1.22M 1.24% 15
2023
Q1
$15M Sell
43,733
-1,381
-3% -$466K 1% 17
2022
Q4
$16.5M Sell
45,114
-668
-1% -$237K 1.08% 14
2022
Q3
$14.8M Buy
45,782
+173
+0.4% +$54.8K 1.08% 15
2022
Q2
$14.8M Sell
45,609
-91
-0.2% -$27.3K 1.04% 17
2022
Q1
$13.1M Buy
45,700
+112
+0.2% +$28.8K 0.8% 20
2021
Q4
$12.6M Sell
45,588
-26
-0.1% -$6.59K 0.74% 21
2021
Q3
$10.5M Sell
45,614
-606
-1% -$150K 0.66% 23
2021
Q2
$10.6M Buy
46,220
+851
+2% +$171K 0.67% 23
2021
Q1
$8.48M Sell
45,369
-850
-2% -$166K 0.56% 27
2020
Q4
$7.8M Sell
46,219
-6,838
-13% -$1.02M 0.57% 28
2020
Q3
$7.85M Sell
53,057
-1,706
-3% -$264K 0.67% 30
2020
Q2
$8.99M Buy
54,763
+165
+0.3% +$25.3K 0.77% 23
2020
Q1
$7.57M Sell
54,598
-773
-1% -$106K 0.76% 23
2019
Q4
$7.28M Buy
55,371
+197
+0.4% +$22.8K 0.55% 29
2019
Q3
$6.17M Buy
55,174
+1,154
+2% +$128K 0.51% 36
2019
Q2
$5.99M Buy
54,020
+2,170
+4% +$256K 0.49% 39
2019
Q1
$6.73M Buy
51,850
+602
+1% +$73.2K 0.57% 35
2018
Q4
$5.93M Buy
51,248
+383
+0.8% +$42.8K 0.58% 33
2018
Q3
$5.46M Buy
50,865
+420
+0.8% +$42K 0.43% 40
2018
Q2
$4.3M Buy
50,445
+3,554
+8% +$292K 0.35% 46
2018
Q1
$3.63M Buy
46,891
+424
+0.9% +$34.1K 0.3% 54
2017
Q4
$3.92M Sell
46,467
-704
-1% -$59.9K 0.32% 50
2017
Q3
$4.04M Sell
47,171
-1,133
-2% -$92.9K 0.34% 51
2017
Q2
$3.98M Buy
48,304
+239
+0.5% +$19.5K 0.34% 51
2017
Q1
$4.04M Buy
48,065
+1,263
+3% +$101K 0.36% 47
2016
Q4
$3.44M Buy
46,802
+12,579
+37% +$937K 0.33% 50
2016
Q3
$2.75M Buy
34,223
+610
+2% +$48.8K 0.29% 57
2016
Q2
$2.65M Sell
33,613
-316
-0.9% -$23.8K 0.3% 58
2016
Q1
$2.44M Buy
33,929
+1,299
+4% +$98.3K 0.27% 61
2015
Q4
$2.75M Buy
32,630
+1,642
+5% +$136K 0.32% 57
2015
Q3
$2.59M Buy
30,988
+1,807
+6% +$153K 0.3% 57
2015
Q2
$2.44M Buy
29,181
+351
+1% +$26.7K 0.26% 63
2015
Q1
$2.1M Sell
28,830
-1,997
-6% -$142K 0.25% 71
2014
Q4
$2.13M Buy
30,827
+2,015
+7% +$136K 0.26% 70
2014
Q3
$1.87M Sell
28,812
-622
-2% -$39.4K 0.25% 76
2014
Q2
$1.83M Sell
29,434
-439
-1% -$26.2K 0.24% 79
2014
Q1
$1.76M Sell
29,873
-1,130
-4% -$63.1K 0.23% 80
2013
Q4
$1.58M Sell
31,003
-30
-0.1% -$1.5K 0.21% 86
2013
Q3
$1.56M Sell
31,033
-100
-0.3% -$5.24K 0.23% 83
2013
Q2
$1.53M Buy
+31,133
New +$1.69M 0.26% 77

Other funds holding LLY

1ST Source Bank's LLY Position: Q1 2026 in Review

1ST Source Bank reduced its Eli Lilly (LLY) stake by 2.8% in Q1 2026, selling an estimated $899K and leaving 30,771 shares worth $28.3M. The position accounts for 1.46% of the portfolio, ranked #12.

1ST Source Bank first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $34M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • 1ST Source Bank held 30,771 shares of Eli Lilly worth $28.3M as of Q1 2026.
  • 1ST Source Bank sold 887 Eli Lilly shares in Q1 2026, an estimated $899K.
  • Eli Lilly made up 1.46% of 1ST Source Bank's portfolio in Q1 2026, its #12 holding.
  • 1ST Source Bank first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • 1ST Source Bank's Eli Lilly position peaked at $34M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on 1ST Source Bank's 13F filing for Q1 2026, filed 4 May 2026.